<?xml version="1.0" encoding="UTF-8"?>
<ref id="B52">
 <label>52</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Schuster</surname>
    <given-names>SJ</given-names>
   </name>
   <name>
    <surname>Bishop</surname>
    <given-names>MR</given-names>
   </name>
   <name>
    <surname>Tam</surname>
    <given-names>CS</given-names>
   </name>
   <name>
    <surname>Waller</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Borchmann</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>McGuirk</surname>
    <given-names>J</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma</article-title>. 
  <source>N Engl J Med</source> (
  <year>2019</year>) 
  <volume>380</volume>(
  <issue>1</issue>):
  <fpage>45</fpage>–
  <lpage>56</lpage>.  
  <pub-id pub-id-type="doi">10.1056/NEJMoa1804980</pub-id>
  <pub-id pub-id-type="pmid">30501490</pub-id>
 </mixed-citation>
</ref>
